BLOOD 2023: Blinatumomab, Low-Intensity Chemotherapy Effective in Adult B-Cell Acute Lymphoblastic Leukemia
Treatment combination demonstrated high rate of remission and minimal residual disease response
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.